Disc Medicine (IRON) Current Leases (2021 - 2026)
Disc Medicine (IRON) posted quarterly Current Leases of $315000.0 for Q2 2026, down 50.16% year-over-year from $632000.0 in Q2 2025, and down 24.82% quarter-over-quarter from $419000.0 in Q1 2026.
Powered by 
Analysis
Disc Medicine (IRON) Current Leases (2021 - 2026) Analysis & Trends
Disc Medicine (IRON) has reported Current Leases for 6 consecutive years, with $315000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Current Leases fell 50.16% year-over-year to $315000.0; the TTM figure through Jun 2026 stood at $315000.0 (down 50.16% YoY), while the FY2025 annual figure was $611000.0, up 370.0% from the prior year.
- Current Leases retreated to $315000.0 in Q2 2026 per IRON's latest filing, from $419000.0 in the prior quarter.
- Across five years, Current Leases topped out at $767000.0 in Q1 2024 and bottomed at $76000.0 in Q3 2024.
- Historically, Current Leases has averaged $453533.3 across 5 years, with a median of $419000.0 in 2026.
- Annual changes were most pronounced in 2024 — Current Leases slumped 80.45% — and 2025, when it soared 763.16%.
- Disc Medicine's Current Leases stood at $307000.0 in 2022, then jumped by 116.61% to $665000.0 in 2023, then plunged by 80.45% to $130000.0 in 2024, then jumped by 370.0% to $611000.0 in 2025, then plunged by 48.45% to $315000.0 in 2026.
- Business Quant data shows IRON's Current Leases at $315000.0 in Q2 2026, $419000.0 in Q1 2026, and $611000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | 11.00 Mn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | 16.75 Mn |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 21.95 Mn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Disc Medicine | 3.08 Bn | 3.08 Bn | - | 315,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 315,000.00 |
| Mar 31, 2026 | 419,000.00 |
| Dec 31, 2025 | 611,000.00 |
| Sep 30, 2025 | 656,000.00 |
| Jun 30, 2025 | 632,000.00 |
| Mar 31, 2025 | 479,000.00 |
| Dec 31, 2024 | 130,000.00 |
| Sep 30, 2024 | 76,000.00 |
| Jun 30, 2024 | 759,000.00 |
| Mar 31, 2024 | 767,000.00 |
| Dec 31, 2023 | 665,000.00 |
| Sep 30, 2023 | 353,000.00 |
| Jun 30, 2023 | 321,000.00 |
| Mar 31, 2023 | 313,000.00 |
| Dec 31, 2022 | 307,000.00 |
| Dec 31, 2021 | 319,000.00 |